Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
Web
NewsPlease enter a web search for web results.
News
WebRider Jet Center and Breast Cancer Awareness Hosting Hangarfest, September 26, 2026
3+ day, 3+ hour ago (295+ words) Doors open at 6pm with live music, beverages, food trucks, and more for the annual fundraiser for Breast Cancer Awareness This is the 18th Hangarfest and the 15th year hosted by Rider Jet Center. The night will be filled with live music, dancing,…...
Rising Costs of 'Natural Beauty' Routines Prompt Shift Toward Long-Term Treatment Solutions
4+ mon, 1+ week ago (477+ words) GREAT NECK, N.Y., April 21, 2026 /PRNewswire/ -- As the natural beauty trend continues to gain momentum, a growing number of consumers are reassessing the true cost of maintaining minimalist skincare and grooming routines. Laser by Aleya reports that clients are increasingly questioning whether…...
Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
3+ day, 3+ hour ago (910+ words) Approval based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca's Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years Second approval for Enhertu in…...
Peer-Reviewed Pilot Study Shows Promise For Improvements in Premenstrual and Menstrual Symptoms Among Participants Using Seed Cycling Supplement with Chasteberry
1+ week, 3+ day ago (364+ words) In a single-arm study with 40 U.S. women enrolled, participants reported reductions in pain, bloating, and period-related sick days over two menstrual cycles NEW YORK, Aug. 25, 2026 /PRNewswire/ -- Two Moons Health, a women's hormonal health company, in collaboration with Citruslabs, today announced the…...
Breast Cancer Continues to Impact Communities; Northwest Ohio Rallies Together to Take Action at Susan G. Komen® Race for the Cure
1+ week, 1+ day ago (307+ words) Annual Event Unites Survivors, Those Living with Metastatic Breast Cancer, Families and Supporters to Raise Critical Funds, Provide Essential Resources and Accelerate Progress Against Breast Cancer This year, Komen aims to raise $300,000 at the Northwest Ohio Race for the Cure....
Lewie Launches the Restore Ritual Kit, Turning Nighttime Smile Care Into a Beauty Ritual
3+ week, 19+ hour ago (378+ words) SAN ANTONIO, Aug. 13, 2026 /PRNewswire/ -- Lewie, the emerging beauty-positioned oral-care brand redefining how consumers care for their smiles, today announced the launch of the Restore Ritual Kit, a premium two-step nighttime ritual created to help consumers rest comfortably and wake up…...
Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic
1+ mon, 10+ hour ago (262+ words) Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and trial design. AZD4241 is an investigational oral therapy known as a PROTAC (proteolysis-targeting chimera), specifically designed to degrade the estrogen receptor, targeting both…...
Maternal Fever During Pregnancy Associated with Higher Risk of Adverse Birth Outcomes, According to New Review led by AHN Maternal Fetal Medicine Physician
1+ mon, 2+ week ago (405+ words) AHN experts advocate for regular folic acid intake as well as acetaminophen use for fever management to best safeguard mothers, newborns PITTSBURGH, July 20, 2026 /PRNewswire/ -- During pregnancy, fever is common, with roughly 1 out of 5 patients reporting the occurrence sometime during their…...
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
1+ mon, 2+ week ago (468+ words) REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and fulvestrant and REVTORPYK combined with fulvestrant reduced the…...
The Hair Removal Method That Predates Laser Is Now the One Some NYC Clients Can't Find Anywhere Else
1+ mon, 2+ week ago (496+ words) Why Laser Has a Blind Spot Laser hair removal has transformed the industry and remains highly effective for clients with sufficient contrast between hair color and skin tone. The technology targets melanin, the pigment that gives hair its color, using…...